Mainz Biomed and TestDNA Drive CRC Innovation at the 10th
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium...
Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium...
Shares concerned: Carbios Market concerned: Euronext Growth Paris Clermont-Ferrand , 10 January 2024 . CARBIOS, , a pioneer in the development and industrialization of biological...
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous09.01.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Provides Year-End Corporate Review 2023 European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Co...
PREVYMIS® now approved in the U.S. and Europe for prophylaxis of Cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R‑])EMA approval triggers a €15 Million Milestone payment to AiCuris and AiCuris is eligible for further milestone p...
Mainz Biomed Provides Year-End Corporate Review 2023...